Literature DB >> 23873252

Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study.

A Amouzegar1, H Delshad, L Mehran, M Tohidi, F Khafaji, F Azizi.   

Abstract

BACKGROUND: Current reference values for thyroid function tests are based on data from different ethnicities and geographical areas. The aim of the present study was to determine reference intervals for thyrotropin (TSH) and free T4 (FT4), based on the criteria of the National Academy of Clinical Biochemistry (NACB) in an Iranian population.
MATERIAL AND METHODS: This study was conducted within the framework of Tehran Thyroid Study (TTS), an ongoing prospective cohort of 5704 randomly selected individuals, age ≥ 20 yr. A total of 2199 individuals (43.3% male, 56.7% female), based on NACB criteria were included in this study. Reference limit analysis was performed for the negative thyroid peroxidase antibody (TPOAb) group.
RESULTS: After applying all exclusion criteria except TPOAb positivity (10.5%), data of 2459 participants remained for analysis. Of these, 953 (43.3%) were males and 1246 (56.7%) were females; the mean ± SD age was 43.53 ± 14.16 yr. The mean ± SD and median+IQR for TSH were 1.77 mU/l ± 1.24 and 1.46 (0.93-2.23) mU/l, respectively. The 2.5th and 97.5th percentiles TSH were 0.32 mU/l and 5.06 mU/l respectively. The mean ± SD and median (IQR) for FT4 for all negative TPOAb subjects were 1.19 ± 0.16 and 1.18 (1.08-1.31) ng/dl respectively.
CONCLUSION: Reference ranges for thyroid function tests need to be derived from national databases. This study determined age and sex specific TSH and FT4 reference ranges in a Tehranian population, which could eventually enable clinicians to classify patients more appropriately.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873252     DOI: 10.3275/9033

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  The value of ultrasonography in predicting autoimmune thyroid disease.

Authors:  O M Pedersen; N P Aardal; T B Larssen; J E Varhaug; O Myking; H Vik-Mo
Journal:  Thyroid       Date:  2000-03       Impact factor: 6.568

2.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

3.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  L M Demers; C A Spencer
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

4.  The reference interval of thyroid-stimulating hormone in Hong Kong Chinese.

Authors:  Angel O K Chan; Y P Iu; C C Shek
Journal:  J Clin Pathol       Date:  2011-03-21       Impact factor: 3.411

5.  Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians.

Authors:  Joseph Meyerovitch; Pnina Rotman-Pikielny; Michael Sherf; Erez Battat; Yair Levy; Martin I Surks
Journal:  Arch Intern Med       Date:  2007-07-23

Review 6.  Thyroid autoimmunity and environment.

Authors:  M L Tanda; E Piantanida; A Lai; V Lombardi; I Dalle Mule; L Liparulo; N Pariani; L Bartalena
Journal:  Horm Metab Res       Date:  2009-04-02       Impact factor: 2.936

7.  Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism.

Authors:  Thomas E Hamilton; Scott Davis; Lynn Onstad; Kenneth J Kopecky
Journal:  J Clin Endocrinol Metab       Date:  2008-01-29       Impact factor: 5.958

8.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.

Authors:  Martin I Surks; Joseph G Hollowell
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

9.  Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice.

Authors:  Laura Boucai; Martin I Surks
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-25       Impact factor: 3.478

10.  Extreme longevity is associated with increased serum thyrotropin.

Authors:  Gil Atzmon; Nir Barzilai; Joseph G Hollowell; Martin I Surks; Ilan Gabriely
Journal:  J Clin Endocrinol Metab       Date:  2009-01-21       Impact factor: 5.958

View more
  17 in total

1.  Reference intervals for thyrotropin in an area of Northern Italy: the Pordenone thyroid study (TRIPP).

Authors:  R Tozzoli; F D'Aurizio; P Metus; A Steffan; C Mazzon; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2018-01-16       Impact factor: 4.256

2.  Incidence of Thyroid Dysfunction Facing Metabolic Syndrome: A Prospective Comparative Study with 9 Years of Follow-Up.

Authors:  Ladan Mehran; Atieh Amouzegar; Hengameh Abdi; Negar Delbari; Elham Madreseh; Maryam Tohidi; Mohammad Ali Mansournia; Fereidoun Azizi
Journal:  Eur Thyroid J       Date:  2021-01-27

3.  Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS).

Authors:  A Amouzegar; M Dehghani; H Abdi; L Mehran; S Masoumi; F Azizi
Journal:  J Endocrinol Invest       Date:  2022-08-04       Impact factor: 5.467

4.  Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.

Authors:  N Saadat; F Azizi; H Abdi; A Amouzegar
Journal:  J Endocrinol Invest       Date:  2022-05-24       Impact factor: 5.467

5.  The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study: Tehran thyroid study (TTS).

Authors:  Batul Birjandi; Fahimeh Ramezani Tehrani; Atieh Amouzegar; Maryam Tohidi; Razieh Bidhendi Yarandi; Feriedoun Azizi
Journal:  BMC Endocr Disord       Date:  2021-05-26       Impact factor: 2.763

Review 6.  Relational Stability in the Expression of Normality, Variation, and Control of Thyroid Function.

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-07       Impact factor: 5.555

7.  The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study.

Authors:  Atieh Amouzegar; Safoora Gharibzadeh; Elham Kazemian; Ladan Mehran; Maryam Tohidi; Fereidoun Azizi
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

8.  Prevalence of Subclinical Hypothyroidism in Chronic Kidney Disease in a Population-based Study: Tehran Thyroid Study.

Authors:  Sara Kazempour-Ardebili; Atefeh Amouzegar; Maryam Tohidi; Atieh Amouzegar; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2021-03-17

9.  Reference Intervals for Serum Thyroid-Stimulating Hormone Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis.

Authors:  Xichang Wang; Yongze Li; Xiaodan Zhai; Haoyu Wang; Fan Zhang; Xiaotong Gao; Shengyu Liu; Weiping Teng; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

10.  Hypothyroidism and Lipid Levels in a Community Based Study (TTS).

Authors:  Shahram Alamdari; Atieh Amouzegar; Maryam Tohidi; Safoora Gharibzadeh; Pouyan Kheirkhah; Parnian Kheirkhah; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2015-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.